Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Annals of Pharmacotherapy
PubMed Pettegrew JW, Klunk WE, Panchalingam K, et al
(2024, November 26)
With the evolution of GLP-1 therapies and the exploration of higher-dose formulations, the demand for higher-volume autoinjectors is increasing
Originally developed to treat type 2 diabetes, it works by activating GLP-1 and GIP receptors, which regulate blood sugar and appetite control
This does not affect our editorial evaluation, and all opinions, ratings, and conclusions in this review are based on our own research
US$ 25.41
US$ 25.13
US$ 25.24
US$ 25.99
US$ 20.38
